| [1] |
Wickberg A,Holmberg L,Adami HO, et al. Sector resection with or without postoperative radiotherapy for stage I breast cancer: 20-year results of a randomized trial[J]. J Clin Oncol, 2014, 32(8): 791-797.
|
| [2] |
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Darby S, McGale P, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials[J]. Lancet, 2011, 378(9804): 1707-1716.
|
| [3] |
Buchholz TA. Radiotherapy and survival in breast cancer[J]. Lancet, 2011, 378(9804): 1680-1682.
|
| [4] |
Fisher B,Wickerham DL,Deutsch M, et al. Breast tumor recurrence following lumpectomy with and without breast irradiation: an overview of recent NSABP findings[J]. Semin Surg Oncol, 1992, 8(3): 153-160.
|
| [5] |
Veronesi U,Saccozzi R,Del Vechio M, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast[J]. N Engl J Med, 1981, 305(1): 6-11.
|
| [6] |
Polgar C,Fodor J,Major T, et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma-5-year results of a randomized trial[J]. Int J Radiat Oncol Biol Phys, 2007, 69(3): 694-702.
|
| [7] |
Kim Y,Prada DS,Trombetta MG, et al. Dosimetric comparison of partial and whole breast external beam irradiation in the treatment of early stage breast cancer[J]. Med Phys, 2007, 34(12): 4640-4648.
|
| [8] |
Sethi RA,No HS,Jozsef G, et al. Comparison of three-dimensional versus intensity-modulated radiotherapy techniques to treat breast and axillary level III and supraclavicular nodes in a prone versus supine position[J]. Radiother Oncol, 2012, 102(1):74-81.
|
| [9] |
Hong L,Hunt M,Chui C, et al. Intensity-modulated tangential beam irradiation of the intact breast[J]. Int J Radiat Oncol Biol Phys, 1999, 44(5):1155-1164.
|
| [10] |
Haviland JS,Owen JR,Dewar JA, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials[J]. Lancet Oncol, 2013, 14(11): 1086-1094.
|
| [11] |
Bartelink H,Horiot JC,Poortmans PM, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial[J]. J Clin Oncol, 2007, 25(22): 3259-3265.
|
| [12] |
Bahadur YA,Constantinescu CT. Tumor bed boost radiotherapy in breast cancer. A review of current techniques[J]. Saudi Med J, 2012, 33(4): 353-366.
|
| [13] |
Pan Q,Calitchi E,Otmezguine Y, et al. Long-term results of exclusive radiotherapy and brachytherapy of breast cancer[J]. Cancer Radiother, 2012, 16(8): 674-680.
|
| [14] |
van der Laan HP,Hurkmans CW,Kuten A, et al. Current technological clinical practice in breast radiotherapy, results of a survey in EORTC-Radiation Oncology Group affiliated institutions[J]. Radiother Oncol, 2010, 94(3): 280-285.
|
| [15] |
Hardee ME,Raza S,Becker SJ, et al. Prone hypofractionated whole-breast radiotherapy without a boost to the tumor bed: comparable toxicity of IMRT versus a 3D conformal technique[J]. Int J Radiat Oncol Biol Phys, 2012, 82(3): e415-423.
|
| [16] |
McDonald MW,Godette KD,Whitaker DJ, et al. Three-year outcomes of breast intensity-modulated radiation therapy with simultaneous integrated boost[J]. Int J Radiat Oncol Biol Phys, 2010, 77(2): 523-530.
|
| [17] |
Veronesi U,Marubini E,Mariani L, et al. Radiotherapy after breastconserving surgery in small breast carcinoma: long-term results of a randomized trial[J]. Ann Oncol, 2001, 12(7): 997-1003.
|
| [18] |
Vicini FA,Goldstein NS,Pass H, et al. Use of pathologic factors to assist in establishing adequacy of excision before radiotherapy in patients treated with breast-conserving therapy[J]. Int J Radiat Oncol Biol Phys, 2004, 60(1): 86-94.
|
| [19] |
Smith BD,Arthur DW,Buchholz TA, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO)[J]. Int J Radiat Oncol Biol Phys, 2009, 209(2): 269-277.
|
| [20] |
Vicini F,Beitsch PD,Quiet CA, et al. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons Mammo Site Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI)[J]. Cancer, 2008, 112(4): 758-766.
|
| [21] |
Vaidya JS,Wenz F,Bulsara M, et al. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomized trial[J]. Lancet, 2014, 383(9917): 603-613.
|
| [22] |
Moon SH,Shin KH,Kim TH, et al. Dosimetric comparison of four different external beam partial breast irradiation techniques: three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, helical tomotherapy, and proton beam therapy[J]. Radiother Oncol, 2009, 90(1): 66-73.
|
| [23] |
Wen B,Hsu H,Formenti-Ujlaki GF, et al. Prone accelerated partial breast irradiation after breast-conserving surgery: compliance to the dosimetry requirements of RTOG-0413[J]. Int J Radiat Oncol Biol Phys, 2012, 84 (4): 910-916.
|
| [24] |
Veronesi U,Orecchia R,Maisonneuve P, et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial[J]. Lancet Oncol, 2013, 14 (13): 1269-1277.
|